It's time to phase out "serologic weak D phenotype" and resolve D types with RHD genotyping including weak D type 4.
Willy Albert FlegelGregory Andrew DenommeJohn T QueenanSusan T JohnsonMargaret A KellerConnie M WesthoffLouis M KatzMeghan DelaneyRalph R VassalloClayton D SimonS Gerald SandlerPublished in: Transfusion (2020)